Keyword search (4,163 papers available)

Newest Concordia Publications (of 75):

Title Authors PubMed ID
1 Nicotine Suppresses Human Memory Th Cell Subsets With Preferential Effects on Central Memory Th Cells in an α7 Nicotinic Acetylcholine Receptor-Dependent Manner Gholizadeh F; Hajiaghayi M; Rahbari N; Choi JS; Heidt S; Como A; Kazerouni M; Kargar M; Pinard-LaRoche A; Shih SCC; Darlington PJ; 41928597
SOH
2 Nebivolol prevents exhausted T cells and enhances cytotoxicity against MCF-7 breast cancer cells in a β2-adrenergic receptor-dependent manner Hajiaghayi M; Gholizadeh F; Rahbari N; Emamnia N; Shih SCC; Darlington PJ; 41906691
SOH
3 Strengthening and Targeted Rehabilitation for Optimal Neuromuscular Gains for chronic BACK pain (STRONG-BACK): protocol for a randomised controlled trial in participants with primary nociceptive pain drivers Fortin M; Rosenstein B; Bertrand C; Vaillancourt N; Wright A; Montpetit C; Macedo L; Elliott J; Cook CE; Tousignant-Laflamme Y; Ma J; Pagé MG; Dover G; Dang-Vu TT; Weber MH; 41876162
SOH
4 A Fully Virtual Graded Exertion Test Is Safe and Feasible in Symptomatic and Asymptomatic Children With Concussion Coupal J; Shabanova D; Gagnon I; Grilli L; Beaulieu C; Teel E; 41816309
SOH
5 Achilles tendon ultrasound-derived properties of the dominant and non-dominant jumping leg of university basketball athletes: relation with performance, range of motion, and injury Soontjens O; Busner J; Fortin M; 41783785
SOH
6 Exploring correlates of weight bias among university students in diverse programs Jeanningros A; Côté M; Forouhar V; Aimé A; Lavallière M; Blackburn P; Maïano C; Alberga AS; Baillot A; 41718586
SOH
7 Beyond the wound: A scoping review of the psychosocial impact of diabetes-related foot ulcers Hanlon M; McGuire BE; MacGilchrist C; Kirwan E; Neachtain DN; Dhatariya K; Blanchette V; Durand H; Dragomir A; McIntosh C; 41721498
SOH
8 The effect of postoperative rehabilitation on outcomes in patients with degenerative cervical myelopathy (DCM): A systematic review Montpetit C; Kobaisi A; Lantz JM; Chauhan RV; Anderson DB; Fortin M; 41693706
SOH
9 The effect of hearing ability on dual-task performance following multi-domain training in older adults with mild cognitive impairment: findings from the SYNERGIC trial Downey RI; Petersen BJ; Mohanathas N; Campos JL; Montero-Odasso M; Bherer L; Pichora-Fuller MK; Bray NW; Burhan AM; Camicioli R; Fraser S; Liu-Ambrose T; Lussier M; Middleton LE; Pieruccini-Faria F; Phillips NA; Li KZH; 41694460
SOH
10 How vigilance states influence source imaging of physiological brain oscillations: evidence from intracranial EEG Wei X; Afnan J; Avigdor T; von Ellenrieder N; Delaire É; Royer J; Ho A; Minato E; Schiller K; Jaber K; Wang YL; Moye M; Bernhardt BC; Lina JM; Grova C; Frauscher B; 41687693
SOH
11 The effectiveness of Cognitive behavioral therapy for insomnia on sleep EEG hyperarousal: a multicentric polysomnographic study Sforza M; Morin CM; Dang-Vu TT; Pomares FB; Perrault AA; Gouin JP; Bušková J; Janku K; Vgontzas A; Fernandez-Mendoza J; Bastien CH; Riemann D; Baglioni C; Carollo G; Casoni F; Zucconi M; Castronovo V; Galbiati A; Ferini-Strambi L; 41688421
SOH
12 Cardiorespiratory fitness in relation to cerebral vascular and metabolic health in older adults with coronary artery disease Sanami S; Tremblay SA; Potvin-Jutras Z; Rezaei A; Sabra D; Gagnon C; Intzandt B; Mainville-Berthiaume A; Wright L; Gayda M; Iglesies-Grau J; Nigam A; Bherer L; Gauthier CJ; 41680492
SOH
13 Greater cardiorespiratory fitness is associated with higher cerebral blood flow and lower oxygen extraction fraction in healthy older adults Sanami S; Rezaei A; Tremblay SA; Potvin-Jutras Z; Sabra D; Intzandt B; Gagnon C; Mainville-Berthiaume A; Wright L; Gayda M; Iglesies-Grau J; Nigam A; Bherer L; Gauthier CJ; 41543005
SOH
14 Aquatic therapy compared to standard care for chronic low back pain: a randomized controlled trial Vaillancourt N; Montpetit C; Rosenstein B; Fortin M; 41527881
SOH
15 The ELEVATE-LBP consortium: exercise &amp, evidence to lead effective vital action in translating excellence for low back pain prevention Sheeran L; McIlroy S; Wong AYL; Anderson DB; Samartzis D; Bogaert L; Domokos B; Spang C; Fortin M; Hodges PW; Bizzini M; Dvorák J; 41507623
SOH

 

Title:Nebivolol prevents exhausted T cells and enhances cytotoxicity against MCF-7 breast cancer cells in a β2-adrenergic receptor-dependent manner
Authors:Hajiaghayi MGholizadeh FRahbari NEmamnia NShih SCCDarlington PJ
Link:https://pubmed.ncbi.nlm.nih.gov/41906691/
DOI:10.1093/cei/uxag018
Publication:Clinical and experimental immunology
Keywords:T cell exhaustioncytotoxic T cellsnebivololtumor microenvironmentβ-adrenergic receptors
PMID:41906691 Category: Date Added:2026-03-30
Dept Affiliation: SOH
1 Department of Biology, School of Health, Concordia University, Montréal, Québec, Canada.
2 Department of Chemical and Materials Engineering, Center for Applied Synthetic Biology, Concordia University, Montréal, Québec, Canada.
3 Department of Electrical and Computer Engineering, School of Health, Concordia University, Montréal, Québec, Canada.
4 Department of Health Kinesiology & Applied Physiology, School of Health, Concordia University, Montréal, Québec, Canada.

Description:

Introduction: Cancers often drive T cells toward an exhausted state characterized by impaired cytotoxicity and upregulation of inhibitory receptors (PD-1, TIM-3, CD38) and transcriptional regulators (TOX, NFATc1). Repeated stimulation in vitro is used to model this process, reflecting chronic antigen exposure in the tumor microenvironment. Stress-derived catecholamines further drive dysfunction through ß-adrenergic receptor (ß-AR) signaling. Here, we examined the impact of nebivolol, an atypical ß1-AR blocker with ß2-biased agonist activity, on T-cell exhaustion and cytotoxicity against breast cancer cells.

Methods: Human CD3+ T cells from healthy participants were activated once (early activation) or four times (repeated activation) using CD3/CD28/CD2 T cell activator. Cells were treated in vitro with nebivolol, terbutaline (ß2-agonist), isoproterenol (ß1/ß2-agonist), and metoprolol (ß1-blocker). Exhaustion markers, including PD-1, TIM-3, CD38, and TOX, were measured by flow cytometry and RT-qPCR; NFATc1 by western blot; TNF and IFN-? by ELISA, and cytotoxicity against MCF-7 breast carcinoma cells by co-culture assays. Disruption of the ß2-AR gene (ADRB2) was achieved using CRISPR/Cas9.

Results: Nebivolol reduced the proportion of TIM-3+CD38+PD-1+ T cells, downregulated TOX and nuclear NFATc1, and restored ADRB2 expression under repeated activation conditions. Nebivolol enhanced TNF secretion and improved cytotoxicity against MCF-7 cells. In contrast, terbutaline and isoproterenol had no significant effect on exhaustion markers or cytotoxicity. Metoprolol did not inhibit nebivolol's activity, indicating that its effects are not ß1-AR-dependent. Disruption of ADRB2 indicated that nebivolol's anti-exhaustion effects are mediated by ß2-AR.

Discussion: These findings show that nebivolol reinvigorates CD4+ and CD8+ T cells following repeated activation, restoring their cytotoxic function against breast cancer cells in vitro. The immunomodulatory activity of Nebivolol is independent of ß1-AR and mediated through ß2-AR, suggesting that biased ß2-AR signaling may represent a potential strategy for modulating T cell exhaustion in the tumor microenvironment.





BookR developed by Sriram Narayanan
for the Concordia University School of Health
Copyright © 2011-2026
Cookie settings
Concordia University